CID 145994626

Leptazoline d

Structural Information

Molecular Formula
C16H22N2O7
SMILES
C[C@H]1[C@@H](N=C(O1)C2=CC=CC=C2O)[C@@H]([C@@H](C(=O)NC(CO)CO)O)O
InChI
InChI=1S/C16H22N2O7/c1-8-12(13(22)14(23)15(24)17-9(6-19)7-20)18-16(25-8)10-4-2-3-5-11(10)21/h2-5,8-9,12-14,19-23H,6-7H2,1H3,(H,17,24)/t8-,12+,13-,14-/m0/s1
InChIKey
XXWREFOKTUTPHF-ISTUKMMPSA-N
Compound name
(2S,3S)-N-(1,3-dihydroxypropan-2-yl)-2,3-dihydroxy-3-[(4S,5S)-2-(2-hydroxyphenyl)-5-methyl-4,5-dihydro-1,3-oxazol-4-yl]propanamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

354.1427 Da
Monoisotopic Mass

-1.7
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 355.14998 181.1
[M+Na]+ 377.13192 183.3
[M-H]- 353.13542 180.5
[M+NH4]+ 372.17652 188.6
[M+K]+ 393.10586 182.4
[M+H-H2O]+ 337.13996 173.6
[M+HCOO]- 399.14090 192.8
[M+CH3COO]- 413.15655 206.3
[M+Na-2H]- 375.11737 177.4
[M]+ 354.14215 179.3
[M]- 354.14325 179.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.